Riskpilot← Back to searchSign inGet full accessJyllinge Tandlægerne P/S
KASActiveCVR 37323357Jyllingecentret 21, 1.Dental practice care activities · NACE 8623Est. 20156 employeeshttp://jyllingetand.dk
Revenue 2024
DKK 6,9M
+4% vs 2023
EBITDA margin
3.1%
-51% vs 2023
Equity ratio
20.2%
Financial strength
Net profit 2024
DKK 0
6 employees
| Revenue | DKK 6,9M | +4% |
| EBITDA | DKK 215K | -51% |
| Net profit | DKK 0 | — |
| Total assets | DKK 3,7M | +3% |
| Equity | DKK 750K | +0% |
| Employees | 6 | — |
Legal name
Jyllinge Tandlægerne P/S
CVR number
37323357
Legal form
Kommanditaktieselskab/Partnerselskab
NACE code
8623 · Dental practice care activities
Founded
21. december 2015
Share capital
DKK 500.000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive tandlægevirksomhed og at udøve enhver aktivitet, der efter ledelsens skøn er forbundet hermed.
Address
Jyllingecentret 21, 1.
Phone
+4546788733
Email
info@jyllingetand.dk
Website
http://jyllingetand.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5.811 | 6.844 | 6.608 | 6.697 | 6.939 |
| Staff expenses | -5.176 | -6.259 | -5.967 | -6.255 | -6.724 |
| EBITDA | 635 | 585 | 641 | 442 | 215 |
| Depreciation & amort. | -590 | -545 | -591 | -377 | -149 |
| EBIT | 46 | 39 | 51 | 65 | 66 |
| Net financials | -46 | -39 | -51 | -65 | -66 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3.280 | 3.173 | 2.761 | 3.606 | 3.720 |
| Equity | 750 | 750 | 750 | 750 | 750 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.530 | 2.423 | 2.011 | 2.856 | 2.970 |
| Total debt | 2.530 | 2.423 | 2.011 | 2.856 | 2.970 |
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
20.2%
This company
38.2%
Market median
-47% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
20202024
Debt / equity
3.96×
This company
0.62×
Market median
-539% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MR Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2015 | |
| Chairman | 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2015 | |
| Individual | 50–66.65% | 50–66.65% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jyllinge Tandlægerne P/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Ryding | Audit | 0 companies |
| Björn Legler | Board of Directors | 0 companies |
| Mikkel Bundgaard-Ovesen | Chairman | 0 companies |